Individual differences mean that the costs of treatment of hypertension cannot readily be quantified

Cardiovasc Drugs Ther. 1990 Dec;4(6):1439-41. doi: 10.1007/BF02026488.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antihypertensive Agents*
  • Contraindications
  • Humans
  • Hypertension / economics*

Substances

  • Antihypertensive Agents